In order to ensure 2023 billing, testing must be activated before the end of the year, or within 30 days of proband sample collection (if sample was collected in 2023). For Exome, Genome, or Xpanded testing, if you do not expect parental samples to be received in time for testing to be activated with 2023 billing, please contact us at email@example.com to determine how to proceed.
For a child with epilepsy, every day without a genetic diagnosis is a missed opportunity.
Uncovering an individual’s genetic etiology with comprehensive genetic testing, such as whole exome sequencing (WES) or whole genome sequencing (WGS), offers a more complete understanding of patient health. A genetic diagnosis can provide patients and families greater access to resources and more effective treatment options.
A genetic diagnosis helps providers tailor treatments and identify, treat and/or prevent co-occurring medical conditions for children with epilepsy. This can include avoiding, stopping, or initiating specific medication or diet recommendations.2
Patients and families can access prognostic information, evaluate potential recurrence risks, discover resources and communities, and explore clinical trial eligibility for their children with a specific genetic diagnosis.2,4
With 30% fewer uncertain results and higher diagnostic yields, exome testing uncovers the answers hiding behind negative panel results.5
Sponsored testing programs contribute to delayed diagnoses with narrow panels that exclude the genetic analyses needed to deliver answers to patients, their families, and their providers. With higher clinical utility, expert endorsements from AES and NSGC, and rapidly increasing accessibility, exome provides definitive answers to end the diagnostic odyssey.
Insurance coverage is expanding. Over 70% of commercial health plans cover exome sequencing for children with neurodevelopmental disorders that meet clinical criteria.6
For many patients, insurance may provide better coverage for exome than multi-gene panels.6
Flexible billing and payment options. Cost shouldn’t be a barrier to getting critical health information. Our billing experts work with families to access testing so patients can get the care they need. We offer flexible payment plans and offer a Financial Assistance Program for eligible patients.
Most GeneDx patients who received exome testing had $0 out-of-pocket responsibility for testing.9
Our dedicated team of genetic counselors provides peer-to-peer support as well as genetic counseling for GeneDx patients at no additional cost, or through our independent partners, pusuant to patient insurance requirements. Our interpretation services focus on providing clinically actionable results, so you can quickly apply findings to your patients’ care plans.
Your patients are looking for answers. Find them with GeneDx.